| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 12/11/2003 | CA2485653A1 Human 5-ht7 receptor promoter sequence |
| 12/11/2003 | CA2485513A1 Modified phytases |
| 12/11/2003 | CA2485411A1 Direct pcr quantification |
| 12/11/2003 | CA2485203A1 Error-prone dna polymerase i mutants and methods for targeted random mutagenesis in continuous culture using error-prone dna polymerase i mutants |
| 12/11/2003 | CA2485111A1 Topical use of at least one double-stranded rna oligonucleotide (ds rna) |
| 12/11/2003 | CA2484629A1 Electrofusion of cells and apparatus therefore |
| 12/11/2003 | CA2484627A1 Cell recovery |
| 12/11/2003 | CA2483145A1 Transgenic plants with controlled distribution of a trait to progeny |
| 12/11/2003 | CA2480326A1 Knockout mice and their use |
| 12/10/2003 | EP1369996A2 Transfection high-voltage controller |
| 12/10/2003 | EP1369695A1 Method for identifying type-I interferon responsive MS patients by determining TRAIL expression |
| 12/10/2003 | EP1369694A1 Method for discrimination of metaplasias from neoplastic or preneoplastic lesions |
| 12/10/2003 | EP1369496A2 Method of making random array of microspheres using enzyme digestion |
| 12/10/2003 | EP1369495A1 Probes for detecting and identifying helicobacter pylori |
| 12/10/2003 | EP1369494A2 Method for ordering macromolecules by means of a moving meniscus and uses thereof |
| 12/10/2003 | EP1369487A2 Recombinant vectors derived from adenovirus for use in gene therapy |
| 12/10/2003 | EP1369486A1 Plasmid shuttle vector between escherichia coli and brevibacillus |
| 12/10/2003 | EP1369485A1 Glucose dehydrogenase |
| 12/10/2003 | EP1369484A1 Plant synthesizing copolyester from monomer derived from short-chain fatty acid and process for producing polyester |
| 12/10/2003 | EP1369483A1 Allergen from mugwort pollen |
| 12/10/2003 | EP1369482A1 Target genes for the diagnosis and treatment of cancer |
| 12/10/2003 | EP1369481A1 Novel translational activity-promoting higher-order structure |
| 12/10/2003 | EP1369480A1 Process for preparation of full-length cDNA and anchor used for the same |
| 12/10/2003 | EP1369479A1 Novel cell adhesion molecule specific to activated leukocyte |
| 12/10/2003 | EP1369476A1 A novel protein, a gene encoding therefor and a method of using the same |
| 12/10/2003 | EP1369431A1 Anti-hla-dr antibody |
| 12/10/2003 | EP1369430A2 Two human G-Protein coupled receptors: EBV-induced GPCR 2(EBI-2) and EBG-1-like GPCR |
| 12/10/2003 | EP1369427A2 HIV-3 retrovirus strains and their use |
| 12/10/2003 | EP1369133A1 Gene carriers with the use of polysaccharide and process for producing the same |
| 12/10/2003 | EP1369120A1 Treatment of flavivirus infection |
| 12/10/2003 | EP1368659A2 Subunit vaccines with a2 supermotifs |
| 12/10/2003 | EP1368655A2 Distinguishing molecular forms |
| 12/10/2003 | EP1368644A2 ANTIBODIES SPECIFIC FOR UNGULATE PrP |
| 12/10/2003 | EP1368630A2 Pin1 as marker for abnormal cell growth |
| 12/10/2003 | EP1368629A1 Magnetic isolation and purification of nucleic acids |
| 12/10/2003 | EP1368501A1 Mutation detection using muts and reca |
| 12/10/2003 | EP1368500A2 Method for preparative production of long nucleic acids by pcr |
| 12/10/2003 | EP1368499A2 Rat toxicologically relevant genes and uses thereof |
| 12/10/2003 | EP1368497A1 Methods and apparatus for analyzing polynucleotide sequences by asynchronous base extension |
| 12/10/2003 | EP1368496A1 Method for alteration detection |
| 12/10/2003 | EP1368495A1 A method of identifying differences between nucleic acid molecules |
| 12/10/2003 | EP1368494A2 Method and test system for identifying substances which protect nerve cells |
| 12/10/2003 | EP1368490A2 Dendritically amplified detection method |
| 12/10/2003 | EP1368489A2 Asynchronous primed pcr |
| 12/10/2003 | EP1368487A1 Methods involving the use of capg as a diagnostic marker and methods for the identification of capg modulators for the treatment and prevention of osteoporosis and related disease states |
| 12/10/2003 | EP1368484A2 Plant genes, the expression of which are altered by pathogen infection |
| 12/10/2003 | EP1368483A2 Process for production of polypeptides |
| 12/10/2003 | EP1368482A2 Nitrile hydratase and a method for producing amides |
| 12/10/2003 | EP1368481A2 Characterization of the i-spoml endonuclease from fission yeast |
| 12/10/2003 | EP1368480A2 Method of modifying the genome of gram-positive bacteria by means of a novel conditionally negative dominant marker gene |
| 12/10/2003 | EP1368479A2 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
| 12/10/2003 | EP1368478A2 Polypeptide inducing hiv-neutralising antibodies |
| 12/10/2003 | EP1368477A1 Vaccine |
| 12/10/2003 | EP1368476A2 Rearranged squamous cell carcinoma antigen genes ii |
| 12/10/2003 | EP1368475A1 Novel nucleic acids and polypeptides |
| 12/10/2003 | EP1368474A1 Polynucleotide useful for modulating cancer cell proliferation |
| 12/10/2003 | EP1368473A2 Neurotransmission-associated proteins |
| 12/10/2003 | EP1368472A2 Molecules for disease detection and treatment |
| 12/10/2003 | EP1368471A2 Compositions and methods relating to prostate specific genes and proteins |
| 12/10/2003 | EP1368470A2 Transcriptional mediators of blood vessel development and endothelial differentiation |
| 12/10/2003 | EP1368469A2 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof |
| 12/10/2003 | EP1368467A2 Putrescine-n-methyltransferase promoter |
| 12/10/2003 | EP1368466A2 Transgenic cell and animal modeling ige-mediated human allergic responses and use thereof |
| 12/10/2003 | EP1368465A2 Recombinant vector containing infectious human cytomegalovirus genome with preserved wild-type characteristics of clinical isolates |
| 12/10/2003 | EP1368464A2 Screening assays for agonists or antagonists of receptor activator of nf-kb |
| 12/10/2003 | EP1368462A2 Bfit (brown fat inducible thioesterase) polypeptides and polynucleotides and their use |
| 12/10/2003 | EP1368460A2 Real-time sequence determination |
| 12/10/2003 | EP1368459A2 Influenza viruses with enhanced transcriptional and replicational capacities |
| 12/10/2003 | EP1368458A2 Interferon-alpha induced gene |
| 12/10/2003 | EP1368457A1 Use of gram-negative bacterial membrane fraction for inducing the maturation of dendritic cells |
| 12/10/2003 | EP1368456A2 Anti-bacterial vaccine compositions |
| 12/10/2003 | EP1368455A1 Transgenic cells and animals for the study of the polarization of the immune response |
| 12/10/2003 | EP1368454A1 Method for detecting a risk of hypertension and uses thereof |
| 12/10/2003 | EP1368403A1 Polymers |
| 12/10/2003 | EP1368378A2 Constitutively desensitized g protein-coupled receptors |
| 12/10/2003 | EP1368377A2 Modified interferon beta with reduced immunogenicity |
| 12/10/2003 | EP1368376A2 Pro-apoptotic proteins and dna molecules encoding them |
| 12/10/2003 | EP1368375A2 Secretory molecules |
| 12/10/2003 | EP1368373A2 Environmentally regulated genes, involved in the virulence of streptococcus suis |
| 12/10/2003 | EP1368371A2 Transfection complexes |
| 12/10/2003 | EP1368368A2 Compositions and methods for binding agglomeration proteins |
| 12/10/2003 | EP1368367A1 Polynucleotide constructs for increased lysine production |
| 12/10/2003 | EP1368061A2 Fusion cells and cytokine compositions for treatment of disease |
| 12/10/2003 | EP1368058A2 Viral reporter particles |
| 12/10/2003 | EP1368054A2 Using neural thread proteins to treat tumors and other hyperproliferative disorders |
| 12/10/2003 | EP1368051A2 Urocortin-iii and uses thereof |
| 12/10/2003 | EP1368020A2 Method for identifying maxi-k channel blockers |
| 12/10/2003 | EP1367998A2 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies |
| 12/10/2003 | EP1367908A2 Expression of human milk proteins in transgenic plants |
| 12/10/2003 | EP1367900A2 Method for controlling harmful organisms in the culture of useful plants |
| 12/10/2003 | EP1367899A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 12/10/2003 | EP1367886A2 Scce modified transgenic mammals and their use as models of human disease |
| 12/10/2003 | EP1367881A2 Plant cell having animal-type sugar chain adding function |
| 12/10/2003 | EP1068216B1 Libraries of oligomers labelled with different tags |
| 12/10/2003 | EP1017365B1 Liposome-entrapped polynucleotide composition and method |
| 12/10/2003 | EP0996735B1 Chimeric vectors comprising a phage packaging site and a portion derived from the genome of a eukaryotic virus |
| 12/10/2003 | EP0996726B1 T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof |
| 12/10/2003 | EP0964870B1 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications |
| 12/10/2003 | EP0958371B1 Cytopathic viruses for therapy and prophylaxis of neoplasia |
| 12/10/2003 | EP0934402B1 High molecular weight trichoderma cellulase |